Navigation Links
Lilly Announces Dividend Increase
Date:12/17/2007

INDIANAPOLIS, Dec. 17 /PRNewswire-FirstCall/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) today announced a 10.6 percent increase in its quarterly dividend. The board declared a dividend for the first quarter of 2008 of $0.47 per share on outstanding common stock. This raises the annual indicated rate to $1.88 per share and represents the 41st consecutive year in which the company has increased the dividend payment.

The dividend is payable March 10, 2008, to shareholders of record at the close of business on February 15, 2008.

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers -- through medicines and information -- for some of the world's most urgent medical needs. Additional information about Lilly is available at http://www.lilly.com. F-LLY

(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
2. Robert J. Heine, M.D., Ph.D., F.R.C.P. to Join Lilly; Distinguished Diabetes Expert to Lead Diabetes/Endocrine Medical Division
3. Lauren Marangell, M.D. to Join Lilly; Internationally Recognized Expert in Depression Joins as Distinguished Lilly Scholar
4. Genentech/Roches Lucentis and Eli Lillys Ruboxistaurin Will Drive the Diabetic Retinopathy and Nephropathy Drug Markets
5. Lillys CEO Calls for Reform of Nations Drug Safety System
6. Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels
7. Lilly Grant to VA Will Enhance Services for Returning Combat Veterans
8. Lilly Delivers Strong Third-Quarter Results
9. Lilly and MacroGenics Announce Licensing and Collaboration Agreement
10. Eli Lilly and Company Aids California Recovery Effort
11. Eli Lilly and Company Announces 2007 Lilly Reintegration Awards Recipients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2008)...y,s sleep-wake system ,can,t remember anything, s... News) -- Your body clock may do more than help gu...y a vital role in learning and memory, say Stanfor...ers, they found that a functioning circadian syste...what they,ve learned. Without it, they "can,t reme...
(Date:10/13/2008)...008 Earnings Conference Call on October 30 - - Pr... Conference on Novemb...estors and Financial Analysts on ...ewswire-FirstCall/ -- Gen-Probe Incorporated,(Nasd...webcast three upcoming,investor events., First, G...
(Date:10/13/2008)...e of six sites included in national study St...rates, OSHKOSH, Wis., Oct. 13 /PRNewswire/ -- Adv...cedcirculatory.com ) announced today that it has,r... the National Institutes,of Health (NIH) to contin...,on those who experience cardiac arrest outside a ...
(Date:10/13/2008)...) Market Leading Content Rights Management System,...p on Their Content Spend, WEST CHESTER, Pa., Oct....that a leading global pharmaceutical manufacturer ...ecome the primary platform for the,secure distribu...ng,analytics for their new product video content. ...
Breaking Medicine News(10 mins):Health News:Circadian Rhythm Plays Role in Memory 2Health News:Gen-Probe Announces Webcasts of Three Upcoming Investor Events 2Health News:Gen-Probe Announces Webcasts of Three Upcoming Investor Events 3Health News:Advanced Circulatory Systems Receives $1.5 Million From NIH for Study of Cardiac Arrest Resuscitation Techniques 2Health News:Global Pharma Integrates Imperium(TM) to Support Launch Content ROI Initiatives! 2
...beer and alcohol increases the risk of colorectal ...the risk, according to a study. // The study, cond...t Stony Brook University, Stony Brook, New York, w...lar alcohol consumption on the detection of signif...
...des are a broad range of user-controlled products ...ally transmitted diseases including AIDS.// It can...e such as a gel, cream, film or suppository. Thes...tiate condom use or to abandon partners who put th...
... Torsten Baldeweg and his colleagues from the Inst... in brain of children’s who were born premature.//...n activity during their life time. The study will ...heir brain which could help to support and assist ...
... subcutaneous tissue, the interstitial fluid press...us tissue of an animal is exposed, fluid does not ... tumor tissue and forms a barrier against efficien...ticancer drugs and antibodies used for treating pa...
Other Medicine News:Health News:Alcohol Drinking Affects Risk Of Colorectal Tumours 2Health News:New Research To Study Brain Changes In Premature Births 2Health News:A Novel Method For Measuring Interstitial Fluid Pressure In Cancer Tissues 2
(Date:10/9/2008)... need to protect the eyesight of,older people, NE...eople worldwide who,are blind, 80 percent are over...ided their blindness if they had been properly dia...elease, go to:, http://www.prnewswire.com/mnr/orbi...products and equipment, is,partnering with nonprof...
(Date:10/8/2008)...-USNewswire/ -- The facts are,overwhelming. Every ...Saharan Africa. More than 35,000,000 women, childr...d of AIDS. The Foundation for Hospices,in Sub-Saha...r families,find compassion and relief from sufferi...ng initiative links African hospices and palliativ...
(Date:10/8/2008)...s Expand Testing Using Cellular ...Oct. 8 /- Wild Blueberry antioxidant,...s from a new study,showing Wild Blueberries outper... apples, bananas, red grapes and strawberries in a...ivity (CAA) assay. New research,published in the c...
(Date:10/7/2008)...rometheus Laboratories Inc., a,specialty pharmaceu...evelopment of PROMETHEUS(R) IBS Diagnostic, the fi...me (IBS). The findings suggest measurable,differen...blood samples,between IBS and non-IBS patients. Th...h a proprietary algorithm, led to the development ...
Breaking Medicine Technology:ORBIS and Alcon Call Attention to the Aging Eye 2ORBIS and Alcon Call Attention to the Aging Eye 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 2In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 4Wild Blueberries Take Top Spot in New Antioxidant Research Study 2Wild Blueberries Take Top Spot in New Antioxidant Research Study 3Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3International Gateway Insurance Brokers Partners With MEDILINQ 708 1International Gateway Insurance Brokers Partners With MEDILINQ 708 2International Gateway Insurance Brokers Partners With MEDILINQ 708 3Study finds heart failure is rare among leukemia patients on imatinib 705 1Study finds heart failure is rare among leukemia patients on imatinib 705 2Study finds heart failure is rare among leukemia patients on imatinib 705 3Temple Emergency Medicine receives 241 8M to find best MRSA treatment 702 1Temple Emergency Medicine receives 241 8M to find best MRSA treatment 702 2Temple Emergency Medicine receives 241 8M to find best MRSA treatment 702 3ABQAURP Announces Certificate Course in Medical Error Prevention 699 1ABQAURP Announces Certificate Course in Medical Error Prevention 699 2
...- Phase I data from XL880, Phase II data from XL99...poster sessions -, SOUTH SAN FRANCISCO, May 30, 20...ced today that data from clinical trials of,the co...will be,presented at the 2007 American Society of ...being held June 1 to 5 in Chicago,Illinois. , , ...
...Investigational Drug Being Pursued for the Treatme...2007 /PRNewswire-FirstCall/ --,Neurobiological Tec...tion of new analysis of data from prior clinical t...pment of their,investigational drug, Viprinex (anc...t the 16th annual European Stroke Congress in,Glas...
Other Medicine Technology:Six Abstracts Featuring Exelixis Compounds Accepted At ASCO,Conference 2Presentations at 2007 European Stroke Congress Highlights New,Direction for Viprinex (ancrod) 2Presentations at 2007 European Stroke Congress Highlights New,Direction for Viprinex (ancrod) 3Presentations at 2007 European Stroke Congress Highlights New,Direction for Viprinex (ancrod) 4
...ce by physicians in office based electrosurgery fo...e power settings, maintain the sterile field and d... to control the function and output of the Hyfreca...d or safety issue is detected. Cost effective alte...
...ost powerful isolated ESU on the market with 10,00...ows the surgeon to adjust power settings from the ...r Plus PC Patented Controlled Output Voltage in CU...utting through various impedance tissues with mini...
Microprocessor-based isolated electrosurgical generator, designed for all general surgical procedures. Unit includes the Valleylab adaptive REM system and Instant Response technology.
Black multi-pinhole occluder
Medicine Products: